Status:

ACTIVE_NOT_RECRUITING

Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection

Lead Sponsor:

Medical University of South Carolina

Collaborating Sponsors:

Grassroots Health Nutrition Institute

ZRT Laboratory

Conditions:

COVID-19

Vitamin D Deficiency

Eligibility:

All Genders

50+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate how useful vitamin D supplementation is in reducing the severity of COVID-19 symptoms and the body's inflammatory and infection-fighting response to COVID-19. ...

Detailed Description

Vitamin D (vitD) deficiency is more prevalent among African Americans and Latinx and in the elderly who have low exposure to sunlight. African Americans and nursing home residents who contract SARS-Co...

Eligibility Criteria

Inclusion

  • Entry Criteria:
  • --Adults aged 50 years of age or older who presents to MUSC or its affiliate hospitals (or associated testing centers) for COVID-19 testing during the recruitment period is eligible for participation.
  • Exclusion Criteria:
  • Hospitalization at the time of study recruitment.
  • Any individual less than 50 years of age. The reason that the participants ≥50 years are being excluded from this study is because those who are ≥50 years have a higher risk of being symptomatic with COVID-19 and have the potential for the greatest benefit. The disease appears to manifest differently in children and its occurrence is quite rare.
  • Only those patients tested for COVID-19 initially will be eligible to participate; therefore, anyone wanting to participate in the trial must have had a COVID-19 test prior to enrollment/participation in the study.
  • Any individual who is not capable of making independent decisions and who is considered cognitively impaired.

Exclusion

    Key Trial Info

    Start Date :

    July 31 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 31 2023

    Estimated Enrollment :

    95 Patients enrolled

    Trial Details

    Trial ID

    NCT04482673

    Start Date

    July 31 2020

    End Date

    December 31 2023

    Last Update

    February 24 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Medical University of South Carolina

    Charleston, South Carolina, United States, 29425